G2GBIO
G2GBIO operates to supply good medicines to patients all over the world and practice.
G2GBIO
Industry:
Delivery Health Care Medical
Founded:
2017-03-01
Address:
Daejeon, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.g2gbio.com
Total Employee:
1+
Status:
Active
Contact:
(82) 42 719 4220
Total Funding:
9.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Nginx PHP YouTube Korea Telecom
Current Employees Featured
Founder
Official Site Inspections
http://www.g2gbio.com
- Host name: 183.111.169.45
- IP address: 183.111.169.45
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "G2GBIO"
G2GBIO ์งํฌ์ง๋ฐ์ด์ค
ํ์ฌ๋ ๊ฐ์ธ์ ๋ณด์ฒ๋ฆฌ๋ฐฉ์นจ์ ํํ์ด์ง(www.g2gbio.com) ์ฒซ ํ๋ฉด์ ๊ณต๊ฐํจ์ผ๋ก์จ ๊ณ ๊ฐ๊ป์ ์ธ์ ๋ ์ฉ์ดํ๊ฒ ๋ณด์ค ์ ์๋๋ก ์กฐ์นํ๊ณ ์์ต๋๋ค. ํ์ฌ๋ ๊ฐ์ธ์ ๋ณด์ฒ๋ฆฌ๋ฐฉ์นจ ์ค ์ค์ํ ์ฌํญ์ด โฆSee details»
G2GBIO - Crunchbase Company Profile & Funding
Organization. G2GBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... G2GBIO closed its last โฆSee details»
G2GBIO Company Profile 2024: Valuation, Funding & Investors
G2GBIO was founded in 2017. Where is G2GBIO headquartered? G2GBIO is headquartered in Cheongju, South Korea. What is the size of G2GBIO? G2GBIO has 50 total employees. What โฆSee details»
G2G Bio - Products, Competitors, Financials, Employees, โฆ
G2gbio.com. Overview & Products; Financials; Founded Year 2017. Stage Bridge | Alive. Total Raised $37.66M. Last Raised $3.61M | 5 mos ago. About G2G Bio. G2G Bio provides drug โฆSee details»
G2GBIO - Company Profile - Tracxn
Nov 5, 2024 G2GBIO ranks 23rd among 48 active competitors. 13 of its competitors are funded while 12 have exited. Overall, G2GBIO and its competitors have raised over $825M in funding โฆSee details»
G2GBIO - Products, Competitors, Financials, Employees, โฆ
G2GBIO is a biotech company. It offers long-acting medicines for patients with chronic diseases such as dementia. The company uses proprietary technology and develops advanced โฆSee details»
G2GBIO - Crunchbase
Organization. G2GBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. โฆSee details»
G2GBIO - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 24, 2020: Series B - โฆSee details»
G2GBIO ์งํฌ์ง๋ฐ์ด์ค
๊ฐ์ธ์ ๋ณด ๋ณดํธ(์ค๋ฆฌ๊ฒฝ์ ์๋ฐ์ ๊ณ )์ฑ ์๊ด : ์ค์ค์ - ๊ฐ์ธ์ ๋ณด ๋ด๋น๋ถ์ : ์ธ์ฌํ - ์ ํ๋ฒํธ : 043-270-6022 - ์ด๋ฉ์ผ : [email protected] ๊ฐ์ธ์ ๋ณด ๋ณดํธ(๋ฌธ์)์ฑ ์๊ด : ์กฐํ์ฐ - ๊ฐ์ธ์ ๋ณด โฆSee details»
G2GBIO Company Profile - Office Locations, Competitors, Revenue โฆ
G2GBIO has 1 employees at their 1 location. See insights on G2GBIO including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
G2GBIO ์งํฌ์ง๋ฐ์ด์ค
G2GBIO Good to the Globe Biotech Company For seven years since its inception in March 2017, G2GBIO has applied for 134 patents, including applications for 81 overseas individual โฆSee details»
G2GBIO ์งํฌ์ง๋ฐ์ด์ค
Meanwhile, in April last year, G2GBio signed a comprehensive cooperation agreement with global pharmaceutical companies to provide contract development organization (CDO) services โฆSee details»
G2GBIO seeks further funds after $9.53M series B financing
Jul 24, 2020 HONG KONG โ Daejeon, South Korea-based biotechnology company G2GBIO Inc. has raised โฉ11.4 billion (US$9.53 million) from a series B financing round, with the funds to โฆSee details»
G2GBIO - Updates, News, Events, Signals & Triggers - Crunchbase
G2GBIO operates to supply good medicines to patients all over the world and practice.See details»
G2GBio to accelerate its CDO·CDMO businesses with new patent โฆ
Aug 12, 2024 G2GBio is leveraging its Innovative Long-Acting Microsphere Platform (InnoLAMP) technology to overcome these limitations. Recently, G2GBio made a โฆSee details»
G2GBIO โFills the Gapโ between โTechnological Barrier and Market โฆ
Mar 8, 2021 G2GBio is developing incrementally modified drugs (IMDs) of efficacies sustainable from weeks to a month via single administration, which are applicable to dementia, diabetes โฆSee details»
G2GBIO ์งํฌ์ง๋ฐ์ด์ค
G2GBio has been conducting various tests on the GMP production line of sustained-release microsphere injections using Micropore Technologiesโ equipment. Heeyong Lee, the CEO of โฆSee details»
Semaglutide biosimilar (G2GBIO) - Drug Targets, Indications
100 Clinical Results associated with Semaglutide biosimilar (G2GBIO) Login to view more data 100 Translational Medicine associated with Semaglutide biosimilar (G2GBIO)See details»
G2GBIO - Contacts, Employees, Board Members, Advisors
Organization. G2GBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. G2GBIO has 1 โฆSee details»
G2GBIO ์งํฌ์ง๋ฐ์ด์ค
Property G2GBIO's technology involves the production of uniform microspheres (10~100ฮผm) by encapsulating drugs with biodegradable polymers Effect The drug is sustainably released over โฆSee details»